NCT01763918 Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2 Status COMPLETED Phase PHASE3
NCT01763905 Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2 Status COMPLETED Phase PHASE3
NCT01763866 LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2 Status COMPLETED Phase PHASE3
NCT01763827 Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2 Status COMPLETED Phase PHASE3
NCT01735149 Efficacy and Safety of Kochujang Pills on Improvement of Blood Lipids Status UNKNOWN Phase PHASE2/PHASE3
NCT01695954 Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz Status COMPLETED Phase PHASE1
NCT01694446 Regulation of Intestinal and Hepatic Lipoprotein Production by Glucose and Fructose Status COMPLETED Phase NA
NCT01680211 Safety and Efficacy Study of Herbal Supplements in Prediabetic and Mild to Moderate Hyperlipidemic Patients Status COMPLETED Phase NA
NCT01671254 Effect of Citrus Bioflavonoids/Vitamin E in Conjunction With Fish Oil Supplementation Status COMPLETED Phase NA
NCT01649986 Nutraceuticals to Improve Lipid Profile in European Countries Status UNKNOWN Phase PHASE4
NCT01647438 Translating a Heart Disease Lifestyle Intervention Into the Community Status COMPLETED Phase NA
NCT01644942 Identification in Obese Patients of the Mechanism Involved in Intramuscular Lipid Accumulation Status COMPLETED Phase NA
NCT01634906 Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy Status COMPLETED Phase NA
NCT01609907 Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan Status COMPLETED Phase PHASE1